Last night, London-based Keregen were crowned the 2015 winners of OneStart Europe, receiving the £100k grand prize – and even better, a year’s free membership of the BIA!
Keregen develops first-in-class medicines for the prevention and treatment of neurodegenerative disease and is currently focussed on disease modifiers for Parkinson’s. Watch Jemma Gatliff, co-founder and CEO of Keregen, give some background to the company in their semi-finalist video from earlier in the competition.
Do you have a video you would like the sector to see? Contact us.